AQUESTIVE THERAPEUTICS
N/A
31-December-69 19:00:00
15 minutes delayed
Stocks
N/A
Today's range
N/A - N/A
ISIN
N/A
Source
NASDAQ
-
28 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
27 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
12 Sep 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Investor Conferences in September
31 Aug 2022 16:02:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film
31 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space
10 Aug 2022 16:50:35 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
02 Aug 2022 16:02:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference
26 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
20 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
11 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
15 Jun 2022 16:22:33 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics, Inc. Announces Closing of $8.5 Million Registered Direct Offering
08 Jun 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
06 Jun 2022 08:30:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces CEO Transition
17 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in H.C. Wainwright Global Investment Conference
10 May 2022 08:00:03 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
03 May 2022 17:40:58 By Nasdaq GlobeNewswire
-
18 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
-
13 Apr 2022 08:00:02 By Nasdaq GlobeNewswire
-
12 Apr 2022 08:00:02 By Nasdaq GlobeNewswire